创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology Luminex Platform: Features and Advantages in Detail

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-01 15:50
  • Views:

(Summary description)In the field of pharmaceutical R&D, high-throughput, efficient and accurate experimental platforms play a crucial role in the discovery and development of new drugs. InnoModels Biotechnology Luminex platform is an innovative experimental tool born to meet this need. Its features and advantages in drug discovery and development are remarkable, providing powerful technical support for researchers.

InnoModels Biotechnology Luminex Platform: Features and Advantages in Detail

(Summary description)In the field of pharmaceutical R&D, high-throughput, efficient and accurate experimental platforms play a crucial role in the discovery and development of new drugs. InnoModels Biotechnology Luminex platform is an innovative experimental tool born to meet this need. Its features and advantages in drug discovery and development are remarkable, providing powerful technical support for researchers.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-01 15:50
  • Views:
Information

In the field of pharmaceutical R&D, high-throughput, efficient and accurate experimental platforms play a crucial role in the discovery and development of new drugs. InnoModels Biotechnology Luminex platform is an innovative experimental tool born to meet this need. Its features and advantages in drug discovery and development are remarkable, providing powerful technical support for researchers.
Features:
1. High-throughput processing capability: The Luminex platform is known for its highly efficient multi-factor detection capability, which is capable of detecting up to 50 different biomarkers simultaneously in one experiment. This high-throughput processing greatly shortens the experimental cycle and improves experimental efficiency.
2. High flexibility: The platform supports a wide range of sample types, such as plasma, urine, cerebrospinal fluid, etc., and can be used in a variety of research scenarios, including drug safety assessment, disease diagnosis, and immunophenotyping.
3. High sensitivity and accuracy: The Luminex platform utilizes advanced bioassay technology to provide extremely high sensitivity and accuracy. This enables researchers to more accurately assess the mechanism of action and biosafety of drugs.
4. Easy to operate and automate: The platform is simple to operate, easy to start, and supports automated operation, which greatly reduces the work intensity of researchers and improves the repeatability and accuracy of experiments.

 


Advantages:
1. Reduced R&D costs: Through high-throughput processing and automated operation, the Luminex platform significantly reduces the cost of drug development. Researchers can simultaneously test multiple biomarkers in one experiment, thus reducing the number of experiments and sample consumption.
2. Improved R&D efficiency: The platform's efficient processing capabilities enable researchers to obtain results faster, shortening the drug discovery cycle. In addition, the high degree of automation reduces human error and improves the accuracy of experiments.
3. Enhanced R&D capabilities: The versatility and flexibility of the Luminex platform enables researchers to gain a more comprehensive understanding of the mechanism of action and biosafety of drugs. This helps researchers discover new drug targets and provides new directions for new drug development.
4. Promote immunology research: The platform has a wide range of applications in immunology research. By detecting a variety of immune-related biomarkers, researchers can gain a deeper understanding of the function of the immune system and the mechanism of disease occurrence, which will provide strong support for the development of immunotherapeutic drugs.
In conclusion, the Luminex platform of InnoModels Biotechnology is playing an increasingly important role in the field of drug discovery and development with its features and advantages such as high throughput, high sensitivity, high accuracy, easy operation and automation. The platform not only reduces the R&D cost and improves the R&D efficiency, but also promotes the in-depth development of immunology research and provides strong technical support for new drug development.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司